| Rank |
Pathway / Axis |
Cancer / Tumor Context |
Normal Tissue Context |
TSF |
Primary Effect |
Notes / Interpretation |
| 1 |
Cellular osmolyte / membrane stabilization |
Stress tolerance modulation (context-dependent) |
Osmoregulation ↑; membrane stability ↑ |
P, R |
Homeostatic buffering |
Taurine is a major organic osmolyte; stabilizes membranes and can reduce stress-induced damage. |
| 2 |
Redox tone modulation (indirect antioxidant) |
Oxidative stress ↓ (reported in some models) |
Oxidative injury ↓ (common in injury models) |
R, G |
Redox buffering |
Taurine is not a classic radical scavenger like polyphenols; benefits are often indirect (mitochondrial + inflammation effects). |
| 3 |
Anti-inflammatory signaling (NF-κB / cytokine tone) |
Inflammatory tumor-support signaling ↓ (reported; model-dependent) |
Inflammation tone ↓ |
R, G |
Anti-inflammatory modulation |
Often reported to reduce pro-inflammatory cytokines and NF-κB-linked outputs in stress/injury contexts. |
| 4 |
Mitochondrial function / bioenergetic stability |
Mitochondrial stress ↓ (context) |
ΔΨm stability ↑; mitochondrial resilience ↑ |
R, G |
Organelle protection |
Commonly framed as improving mitochondrial resilience under stress (ischemia/toxicity models); cancer direction is context-dependent. |
| 5 |
Calcium handling (Ca2+ homeostasis) |
Stress signaling modulation (context) |
Ca2+ buffering / excitability modulation |
P, R |
Signal stabilization |
Taurine is often described as modulating Ca2+ fluxes and reducing Ca2+-overload injury. |
| 6 |
ER stress / UPR modulation |
ER stress ↓ (reported in some systems) |
Proteostasis protection ↑ |
R, G |
Proteotoxic stress buffering |
Reported to blunt ER-stress signaling in some injury models; cancer relevance depends on whether ER stress is pro-death or pro-survival in that tumor. |
| 7 |
Apoptosis modulation (context-dependent) |
Apoptosis ↑ or ↓ depending on model |
Often anti-apoptotic under toxic stress |
G |
Cell-fate modulation |
Most consistent pattern is protection in normal tissues; direct tumor-killing is not a dominant taurine signature. |
| 8 |
Bile acid conjugation / metabolic handling |
Indirect systemic metabolism effects |
Bile acid conjugation ↑; lipid handling modulation |
G |
Systemic metabolic support |
Taurine is used for bile acid conjugation; may affect gut-liver signaling indirectly. |
| 9 |
Chemo-/radioprotection signals (adjunct angle) |
Could reduce oxidative injury (might reduce efficacy for ROS-driven modalities) |
Normal tissue protection potential |
G |
Supportive-care relevance |
If positioned, best framed as “supportive/normal-tissue buffering” and kept separate from “tumor kill” claims. |
| 10 |
Translation constraint (not a primary anti-cancer agent) |
Direct anti-tumor efficacy is inconsistent / model-dependent |
Generally well-tolerated in typical dietary ranges |
— |
Expectation management |
Best classified as a homeostasis modulator; cancer claims should be qualified and tied to specific models. |
| Rank |
Pathway / Axis |
AD / Brain Context |
TSF |
Primary Effect |
Notes / Interpretation |
| 1 |
Neuroinflammation (microglia / cytokine tone) |
Inflammatory signaling ↓ (reported in neuroinflammation models) |
R, G |
Anti-inflammatory modulation |
Taurine and taurine-derived signals are often discussed as dampening pro-inflammatory cytokine output; relevance is strongest where inflammation drives synaptic dysfunction. |
| 2 |
Oxidative stress / redox buffering |
ROS injury ↓; lipid peroxidation ↓ (reported) |
R, G |
Neuroprotection (stress buffering) |
Taurine is not a classic polyphenol antioxidant; protective effects are typically indirect (mitochondrial stabilization, inflammation reduction). |
| 3 |
Mitochondrial function / energy stability |
ΔΨm stability ↑; mitochondrial stress ↓ (reported) |
R, G |
Bioenergetic support |
AD is associated with mitochondrial dysfunction; taurine is often positioned as improving resilience under metabolic/oxidative stress. |
| 4 |
Calcium handling / excitotoxicity buffering |
Ca2+ dysregulation ↓; excitotoxic pressure ↓ (reported) |
P, R |
Signal stabilization |
Taurine is frequently described as modulating Ca2+ flux and reducing Ca2+-overload injury, which can be relevant to excitotoxic synapse loss. |
| 5 |
Osmoregulation / membrane stabilization |
Cell volume + membrane stability ↑ |
P, R |
Cellular resilience |
As a major osmolyte, taurine can stabilize membranes and reduce stress-induced injury in neurons and glia. |
| 6 |
ER stress / UPR modulation |
ER stress ↓; proteostasis pressure ↓ (reported) |
R, G |
Proteostasis support |
Protein-misfolding/UPR burden is relevant in neurodegeneration; taurine is reported to buffer ER stress in several injury models. |
| 7 |
Synaptic function support (neurotransmission tone) |
Synaptic resilience ↑ (reported) |
G |
Functional support |
Taurine can act as a neuromodulator (inhibitory tone) and may support synaptic stability indirectly via reduced inflammation/oxidative stress. |
| 8 |
Aβ / Tau pathology (direct effects) |
Mixed / limited direct evidence; indirect effects via inflammation/redox more plausible |
G |
Downstream pathology modulation (uncertain) |
If included, keep conservative: taurine is more strongly supported as a stress-buffering agent than a direct anti-amyloid or anti-tau drug. |
| 9 |
BBB / CNS exposure |
CNS availability depends on transport; dietary taurine raises systemic levels |
R |
PK constraint |
Taurine is abundant in brain but transport and distribution still matter; effects depend on achievable CNS shifts. |
| 10 |
Translation constraint (adjunct positioning) |
Supportive neuroprotection likely; disease-modifying AD benefit not established |
— |
Expectation management |
Best positioned as neuroprotective / resilience-supporting; avoid claiming proven disease modification without trial-level support. |